Rossari Biotech vs Peers
- Market cap
- ₹2,268 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹294.80 – ₹552.76
Rossari Biotech ranks 1st by market capitalisation among 1 Specialty Chemicals companies tracked by ATS. Its largest peers are Rossari Biotech. Its P/E of 22.5 compares with a peer median of 22.5.
Rossari Biotech vs Specialty Chemicals peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| Rossari Biotech | 409.45 | -3.18% | 2,268 | 22.5 | 2.85 | 14.5% | +18.5% |
| Rossari Biotech | 409.45 | -3.18% | 2,268 | 22.5 | 2.85 | 14.5% | +24.5% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 9 October 2026. How this data is compiled.
Rossari Biotech peer comparison — frequently asked questions
Who are Rossari Biotech's competitors?
Rossari Biotech's listed peers in Specialty Chemicals include Rossari Biotech, ranked here by market capitalisation.
How does Rossari Biotech's P/E compare with its peers?
Rossari Biotech trades at a P/E of 22.5, against a median of 22.5 across the 1 Specialty Chemicals peers shown.
Which is the largest company among Rossari Biotech's peers?
By market capitalisation, the largest company in the group is Rossari Biotech at ₹2,268 crore, against ₹2,268 crore for Rossari Biotech.
Same Data For Peers
Trade Rossari Biotech With ATS
Track ROSSARI live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.